Get started
Author

Maaz Kamal Alata

Observed name: Maaz Alata
ORCID: 0000-0001-5227-4618
Observed ORCID: 0000-0001-5227-4618
OpenAlex ID: A5000069604
Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights
2024 · Heng Joo Ng, Maaz Kamal Alata, et al. · Clinical and Experimental Medicine · 9
Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer
2022 · Bader Alshamsan, Ahmed Mostafa Gad, et al. · Journal of Oncology · 4
PDF
Molecular Signature of Cisplatin Resistance in Ovarian Cancer Identifies Therapeutic Opportunities for Re-sensitization
2025 · Mahmoud Mansour, Sabrina van Ginkel, et al. · Journal of Cancer · 3
PDF
Resectability rate of pancreatic cancer after neoadjuvant therapy.
2024 · Ali H Aljubran, Maaz Kamal Alata, et al. · Journal of Clinical Oncology · 3
Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria
2020 · Jamal Zekri, Meteb Al-Foheidi, et al. · Breast Care · 3
Decisions on adjuvant chemotherapy for patients with breast cancer based on clinical and evolving Oncotype DX criteria.
2019 · Jamal Zekri, Meteb Owaish Al-Foheidi, et al. · Journal of Clinical Oncology · 2
Conversion and resection rates in borderline resectable and locally advanced pancreatic cancer following neoadjuvant therapy: a retrospective multicenter cohort study
2026 · Ali H. Aljubran, Maaz Kamal Alata, et al. · Frontiers in Oncology · 1
PDF
The outcome of vincristine, dactinomycin D, ifosfamide and doxorubicin (VAIA) as first-line therapy for adult-patients with metastatic ewing sarcoma; a single-center experience.
2020 · Jean Paul Atallah, Mahmoud Abdelsatar Elshenawy, et al. · Journal of Clinical Oncology · 1
Abstract A025: Molecular signature of cisplatin resistance in ovarian cancer identifies therapeutic opportunities for re-sensitization
2025 · Mahmoud Mansour, Sabrina Van Ginkel, et al. · Cancer Research
Prognostic factors and treatment outcomes of adult Ewing sarcoma from 20 years of experience in a specialized center
2025 · Bader Alshamsan, Mahmoud A. Elshenawy, et al. · International Journal of Health Sciences
Capecitabine therapy in recurrent/metastatic nasopharyngeal cancers.
2020 · Bader I Alshamsan, Maaz Kamal Alata, et al. · Journal of Clinical Oncology
Works count: 11
Citation count: 26
H-index: 3
I10-index:
Year
Topic
Type